16 October 2020 in Diabetologia
Aims/hypothesis: We aimed to determine the association of depression with dementia risk in people with type 2 diabetes, and to explore the possible mediating role of inflammation in this relationship. Methods: The Edinburgh Type 2 Diabetes Study is a prospective cohort of 1066 men and women with type 2 diabetes aged 60–75 years. Cox proportional hazards regression analysis was used to investigate the association between depression, assessed at baseline, and subsequent risk of dementia over 10 years. Depression was defined using the Hospital Anxiety and Depression Scale, while incident dementia was defined using medical records, prescription data and death certificates. The potential mediating effect of systemic inflammation was assessed by adjusting models for a generalised inflammation factor, derived from four inflammatory markers measured at baseline (C-reactive protein, IL-6, TNF-α and fibrinogen), and carrying out an exploratory mediation analysis. Results: Dementia developed in 105 participants over a median follow-up of 10.6 years. After adjusting for age and sex, depression was associated with over a 2.5-fold increase in risk of dementia (HR 2.59 [95% CI 1.62, 4.15]). Additional adjustment for the generalised inflammation factor and other covariates did not attenuate the size of association between depression and incident dementia and mediation analysis showed that it was not a mediator. Adjusted logistic regression models showed cross-sectional associations of C-reactive protein and IL-6 with depression. Conclusions/interpretation: Depression is an important risk factor for dementia in people with type 2 diabetes. Some inflammatory markers were associated with depression, but systemic inflammation does not appear to mediate the relationship between depression and dementia.
21 December 2023 in Public Health
There is uncertainty about which factors mediate the association between adverse childhood experiences (ACEs) and cardiovascular disease (CVD). This could inform secondary prevention targets. Mediation analysis of a prospective cohort study. English Longitudinal Study of Ageing (ELSA) wave 3 data (2006/7) were used to measure retrospective exposure to 12 individual ACEs and waves 2 to 4 (2004/5 to 2008/9) data to measure current exposure to potential mediators [smoking, physical activity, alcohol consumption, body mass index, depression, and C-reactive protein (CRP)]. Waves 4 to 9 ELSA data (2008/9 to 2018/19) were used to measure incident CVD. Cumulative ACE exposure was categorised into experiencing 0, 1 to 3, or ≥4 individual ACEs. Associations were tested between ACE categories, potential mediators, and incident CVD, to inform which variables were analysed in causal mediation models. The analytical cohort consisted of 4547 participants (56% women), with a mean age of 64 years (standard deviation = 9 years). At least one ACE had been experienced by 45% of the cohort, and 24% developed incident CVD over a median follow-up period of 9.7 years (interquartile range: 5.3-11.4 years). After adjusting for potential confounders, experiencing ≥4 ACEs compared with none was associated with incident CVD [odds ratio (OR): 1.55; 95% confidence interval (CI): 1.10, 2.17], and the association of one to three ACEs compared with none was non-significant (OR: 1.08; 95% CI: 0.93, 1.24). There were two statistically significant mediators of the association between ≥4 ACEs and incident CVD: CRP and depression, which accounted for 10.7% and 10.8% of the association, respectively. Inflammation and depression partially mediated the association between ACEs and CVD. Targeting these factors may reduce the future incidence of CVD.
22 August 2023 in Public Health in Practice
29 April 2026 in Journal of Multimorbidity and Comorbidity
Background: Childhood socioeconomic disadvantage is linked to individual chronic diseases in adulthood, but its relationship with multimorbidity remains unclear. Understanding this is crucial for informing prevention strategies and the economic case for investment. This review and meta-analysis evaluated the association between childhood disadvantage and adult multimorbidity. Methods: Following pre-registration (PROSPERO: CRD42024588657), we searched MEDLINE, SocIndex, ASSIA, and ProQuest Public Health to March 2025 for studies assessing childhood socioeconomic circumstances (SECs) and adult multimorbidity (≥2 chronic conditions). Risk of bias was assessed using ROBINS-E and evidence certainty using GRADE. Random-effects meta-analysis and synthesis without meta-analysis (SWiM) were conducted. Subgroup analyses explored heterogeneity by region, design, and exposure type. Results: From 5,617 records, 10 studies met inclusion criteria. Most were cross-sectional, using retrospective reports of exposure and self-reported outcomes. Exposures included perceived childhood economic adversity (n=6), parental education (n=4), parental occupation (n=1), and composite measures (n=3). Meta-analyses found no clear associations for perceived adversity (OR 1.08, 95% CI 0.87–1.23; I 2 = 94.4%) or parental education (father’s (Odds ratio (OR) 0.95, 95% CI 0.66–1.37; I 2 = 66.8%); mother’s (OR 1.07, 95% CI 0.70–1.61; I 2 = 36.9%)). Relative Index of Inequality estimates generally indicated higher mortality risk with greater childhood disadvantage, though effect sizes varied widely and some studies suggested the reverse.. All studies were high/very high risk of bias with very low certainty. Conclusions: Evidence for an association between childhood socioeconomic disadvantage and adult multimorbidity is limited and uncertain. Findings suggest possible harmful effects but remain constrained by methodological weaknesses and heterogeneity. High-quality longitudinal studies with standardised multimorbidity definitions are needed.
5 May 2025 in Journal of Multimorbidity and Comorbidity
Introduction: Preventing or delaying multimorbidity (people living with two or more chronic conditions) is a public health priority. It is currently uncertain if multimorbidity is associated with features of the built environment, a term describing human-made or modified features of the surroundings in which humans live. Aims: To undertake a systematic review of the literature to determine if built environment features and interventions are associated with multimorbidity and to review the analytical methods used and their implications for causal inference. Methods: Four databases will be searched (Medline, Embase, Science Citation Index Expanded, and Social Sciences Citation Index) using a prespecified search strategy that incorporates terms for both multimorbidity and the built environment, which includes aspects of neighbourhood design, transport interventions, natural environment, food environments, and housing. Inclusion criteria will include: 1) involves community-based adult populations not selected based on an index condition; and 2) a built environment exposure or intervention was assessed; and 3) outcomes include multimorbidity prevalence, incidence, or trajectory. Reference lists of included studies and previous reviews will also be searched. Two reviewers will independently screen, data extract, and quality appraise (using the ROBINS-E or RoB 2 tool). Results will be synthesised by meta-analysis or, if heterogeneity is too great, according to Synthesis without meta-analysis (SWiM) guidelines. Results will be grouped by type of exposure or intervention and by study quality. Conclusions: This systematic review will improve understanding of built environment associations with multimorbidity. It could identify aetiological pathways that support the development of multimorbidity-preventative strategies.